Table 4.

Primary effectiveness and safety outcomes, according to fracture site

Outcomes	Femoral neck fracture			Intertrochanteric fracture of the femur
	Aspirin	Rivaroxaban		Aspirin	Rivaroxaban
	n = 72	n = 69	P‐value	n = 126	n = 123	P‐value
	no.(%)			no.(%)
Venous thromboembolism	6(8.33)	4(5.8)	0.745	7(5.56)	7(5.56)	1.00
Pulmonary embolism	0	0	‐	1(0.79)	0	1.00
Major bleeding	1(1.39)	1(1.45)	1.00	1(0.79)	0	1.00
Clinically relevant bleeding	1(1.39)	1(1.45)	1.00	1(0.79)	2(1.63)	0.61
Minor bleeding	1(1.39)	1(1.45)	1.00	0	1(0.81)	0.49
Any bleeding	3(4.17)	3(4.35)	1.00	2(1.59)	3(2.44)	0.68